Hier vindt u een chronologisch overzicht van wetenschappelijke publicaties in 2015, gepubliceerd door de klinische onderzoeksgroepen die betrokken zijn bij ATHENA/SHM.


The impact of transient cART in early HIV infection on viral suppression and immunologic response in later treatment
Pantazis N, Touloumi G, Meyer L, Olson A, Costagliola D, Kelleher AD, Lutsar I, Chaix ML, Fisher M, Moreno S, Porter K; CASCADE Collaboration in EuroCoord.
AIDS. 2015 Dec 3. [Epub ahead of print] Abstract

Using observational data to emulate a randomized trial of dynamic treatment-switching strategies: an application to antiretroviral therapy
Cain LE, Saag MS, Petersen M, May MT, Ingle SM, Logan R, Robins JM, Abgrall S, Shepherd BE, Deeks SG, Gill MJ, Touloumi G, Vourli G,Dabis F, Vandenhende MA, Reiss P, van Sighem A, Samji H, Hogg RS, Rybniker J, Sabin CA, Jose S, Del Amo J, Moreno S, Rodríguez B, Cozzi-Lepri A, Boswell SL, Stephan C, Pérez-Hoyos S, Jarrin I, Guest JL, Monforte AD, Antinori A, Moore R, Campbell CN, Casabona J, Meyer L, Seng R, Phillips AN, Bucher HC, Egger M, Mugavero MJ, Haubrich R, Geng EH, Olson A, Eron JJ, Napravnik S, Kitahata MM, Van Rompaey SE, Teira R, Justice AC, Tate JP, Costagliola D, Sterne JA, Hernán MA; Antiretroviral Therapy Cohort Collaboration, the Centers for AIDS Research Network of Integrated Clinical Systems, and the HIV-CAUSAL Collaboration.
Int J Epidemiol. 2015 Dec 31. pii: dyv295. [Epub ahead of print] Abstract

TB-HIV co-infection in the Netherlands: estimating prevalence and under-reporting in national registration databases using a capture-recapture analysis
van Leth F, Evenblij K, Wit F, Kiers A, Sprenger H, Verhagen M, Hillebregt M, Kalisvaart N, Schimmel H, Verbon A
J Epidemiol Community Health. 2015 Dec 23. pii: jech-2015-206680. doi: 10.1136/jech-2015-206680. [Epub ahead of print] Abstract

Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) from 2010 to
The late presenters working group in COHERE in EuroCoord
Eurosurveillance 2015 Nov 26;20(47) Artikel

Mortality of treated HIV-1 positive individuals according to viral subtype in Europe and Canada: collaborative cohort analysis
Antiretroviral Therapy Cohort Collaboration (ART-CC), Canadian Observational Cohort Collaboration (CANOC), The UK Collaborative HIV Cohort Study (UK CHIC), the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE).
AIDS 2015 Nov 10 [Epub ahead of print] Abstract

Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV+ persons with a normal baseline eGFR : A prospective international cohort study
Mocroft A, Lundgren JD, Ross M, Fux CA, Reiss P, Moranne O, Morlat P, d'Arminio Montforte A, Kirk O, Ryom L for the Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) Study
Lancet HIV 2015 Nov 16 Artikel

CD4 cell dynamics in untreated HIV-1 infection: overall rates, and effects of age, viral load, gender and calendar time
Cori A, Pickles M, van Sighem A, Gras L, Bezemer D, Reiss P, Fraser C.
AIDS. 2015 Nov 28;29(18):2435-46 Abstract

Mortality in migrants living with HIV in western Europe (1997–2013): a collaborative cohort study
The Migrants Working Group on behalf of COHERE in EuroCoord
Lancet HIV Dec 2015;2(12):e540-e549 Abstract

Cerebral injury in perinatally HIV-infected children compared to matched healthy controls
Cohen S, Caan MWA, Mutsaerts J, Scherpbier HJ, Kuijpers TW, Reiss P, Majoie CBLM, and Pajkrt D
Neurology 2015 Nov 11[Epub ahead of print] Abstract

Health-related quality of life in perinatally HIV-infected children in the Netherlands
Cohen S, Ter Stege JA, Weijsenfeld AM, van der Plas A, Kuijpers TW, Reiss P, Scherpbier HJ, Haverman L, Pajkrt D.
AIDS Care. 2015 Oct;27(10):1279-88 Abstract

Hepatitis C seroconversions in HIV infection across Europe: which regions and patient groups are affected?
Boesecke C, Grint D, Soriano V, Lundgren JD, d'Arminio Monforte A, Mitsura VM, Chentsova N, Hadziosmanovic V, Kirk O, Mocroft A, Peters L, Rockstroh JK; EuroSIDA in EuroCoord.
Liver Int. 2015 Nov;35(11):2384-91 Abstract

Does rapid HIV disease progression prior to cART hinder optimal CD4+ T-cell recovery once HIV-1 suppression is achieved?
Jarrin I, Pantazis N, Dalmau J, Phillips AN, Olson A, Mussini C, Boufassa F, Costagliola D, Porter K, Blanco J, Del Amo J, Martinez-Picado J for CASCADE Collaboration in EuroCoord.
AIDS. 2015 Nov;29(17):2323-33 Abstract

Effect of abacavir on sustained virologic response to HCV treatment in HIV/HCV co-infected patients, Cohere in Eurocoord.
Hepatitis C- working group for COHERE in Eurocoord, Smit C, Arends J, Peters L, Montforte A, Dabis F, Zangerle R, Daikos G, Mussini C, Mallolas J, de Wit S, Zinkernagel A, Cosin J, Chene G, Raben D, Rockstroh J
BMC Infect Dis. 2015 Nov 4;15:498. doi: 10.1186/s12879-015-1224-1. Abstract

Dispersion of the HIV-1 epidemic in men who have sex with men in the Netherlands: A combined mathematical model and phylogenetic analysis
Bezemer D, Cori A, Ratmann O, van Sighem A, Hermanides HS, Dutilh BE, Gras L, Faria NR, van den Hengel R, Duits AJ, Reiss P, de Wolf F, Fraser A, ATHENA observational cohort
PLoS Med 12(11):e1001898 Abstract

Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with eitherraltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143randomised trial.
Bernardino JI, Mocroft A, Mallon PW, Wallet C, Gerstoft J, Russell C, Reiss P, Katlama C, De Wit S, Richert L, Babiker A, Buño A, Castagna A,Girard PM, Chene G, Raffi F, Arribas JR; NEAT001/ANRS143 Study Group.
Lancet HIV. 2015 Nov;2(11):e464-73 Abstract

Acute Hepatitis C in the Netherlands; characteristics of the epidemic in 2014
Hullegie SJ, van den Berk GE, Leyten EM, Arends JE, Lauw FN, van der Meer JT, Posthouwer D, van Eeden A, Koopmans PP, Richter C, van Kasteren ME, Kroon FP, Bierman WF, Groeneveld PH, Lettinga KD, Soetekouw R, Peters EJ, Verhagen DW, van Sighem AI, Claassen MA, Rijnders BJ
Clin Microbiol Infect. 2015 Oct 16. pii: S1198-743X(15)00911-8 Abstract

Comparative effectiveness of strategies for antiretroviral treatment initiation in HIV-positive individuals in high-income countries: observational cohort study
Lodi S, Phillips A, Logan R, Olson A, Costagliola D, Abgrall S, van Sighem A, Reiss P, Miro JM, Ferrer E, Justice A, Gandhi N, Bucher HC, Furrer H, Moreno S, Monge S, Toulomi G, Pantazis N, Sterne J, Young JG, Meyer L, Seng R, Dabis F, Vandehende MA, Perez-Hoyos S, Jarrin I, Jose S, Sabin C, Hernan MA, on behalf of the HIV-CAUSAL Collaboration
The Lancet HIV 2015; 2(8):e335–e343 Abstract

Favourable SVR12 rates in boceprevir or telaprevir triple therapy in HIV/ HCV coinfected patients
Arends JE, van der Meer JTM, Posthouwer D, Kortmann W, Brinkman K, van Assen S, Smit C, van der Valk M, van der Ende M, Schinkel J, Reiss P, Richter C, Hoepelman AIM, on behalf of Stichting HIV Monitoring/Nederlandse Vereniging van HIV Behandelaren Hepatitis Working Group, and the ATHENA national observational HIV cohort
Neth J Med 2015 Aug;73(7):324-330 Abstract

Changes in HIV RNA and CD4 cell count after acute HCV infection in chronically HIV-infected individuals
Gras L, de Wolf F, Smit C, Prins M, van der Meer JT, Vanhommerig JW, Zwinderman AH, Schinkel J, Geskus RB; ATHENA national observational cohort and the MOSAIC study
J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):536-42 Abstract

Risk factors for sexual transmission of hepatitis C virus among human immunodeficiency virus-infected men who have sex with men: a case-control study
Vanhommerig JW, Lambers FA, Schinkel J, Geskus RB, Arends JE, van de Laar TJ, Lauw FN, Brinkman K, Gras L, Rijnders BJ, van der Meer JT,Prins M; MOSAIC (MSM Observational Study of Acute Infection With Hepatitis C) Study Group, van der Meer JT, Molenkamp R, Mutschelknauss M, Nobel HE,Reesink HW, Schinkel J, van der Valk M, van den Berk GE, Brinkman K, Kwa D, van der Meche N, Toonen A, Vos D, van Broekhuizen M, Lauw FN, Mulder JW,Arends JE, van Kessel A, de Kroon I, Boonstra A, van der Ende ME, Hullegie S, Rijnders BJ, van de Laar TJ, Gras L, Smit C, Lambers FA, Prins M,Vanhommerig JW, van der Veldt W.
Open Forum Infect Dis. 2015 Aug 6;2(3):ofv115  Abstract

Impact of male circumcision among heterosexual HIV cases: comparisons between three low HIV prevalence countries
Chemtob D, Op de Coul E, van Sighem A, Mor Z, Cazein F, Semaille C
Isr J Health Policy Res. 2015 Aug 4;4:36 Abstract

Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study.
Achhra AC, Mocroft A, Reiss P, Sabin C, Ryom L, de Wit S, Smith CJ, d'Arminio Monforte A, Phillips A, Weber R, Lundgren J, Law MG; D:A:D StudyGroup.
HIV Med. 2015 Jul 28. doi: 10.1111/hiv.12294. [Epub ahead of print] Abstract

Poorer cognitive performance in perinatally HIV-infected children versus healthy socioeconomically matched controls.
Cohen S, Ter Stege JA, Geurtsen GJ, Scherpbier HJ, Kuijpers TW, Reiss P, Schmand B, Pajkrt D
Clin Infect Dis. 2015 Apr 1;60(7):1111-9. Abstract

Risk of non-AIDS-defining events among HIV-infected patients not yet on antiretroviral therapy.
Zhang S, van Sighem A, Kesselring A, Gras L, Prins JM, Hassink E, Kauffmann R, Richter C, de Wolf F, Reiss P; ATHENA national observational HIV cohort study
HIV Med. 2015 May;16(5):265-72 Abstract

Anal cancer in the HIV positive population: Slowly declining incidence after a decade of cART
Richel O, Van der Zee R , Smit C, De Vries H, Prins J
J Acquir Immune Defic Syndr. 2015 Aug 15;69(5):602-5 Abstract

Estimating HIV incidence, time to diagnosis, and the undiagnosed HIV epidemic using routine surveillance data
Sighem AV, Nakagawa F, Angelis D, Quinten C, Bezemer D, Coul EO, Egger M, Wolf F, Fraser C, Phillips A
Epidemiology. 2015 Jul 21. [Epub ahead of print] Abstract

Long-term changes of subcutaneous fat mass in HIV-infected children on antiretroviral therapy: A retrospective analysis of longitudinal data from two pediatric HIV cohorts
Cohen S, Innes S, Geelen SP, Wells JC, Smit C, Wolfs TF, van Eck-Smit BL, Kuijpers TW, Reiss P, Scherpbier HJ, Pajkrt D, Bunders MJ
PLoS One. 2015 Jul 6;10(7):e0120927 Abstract

Future challenges for clinical care of an ageing population infected with HIV: a modelling study.
Smit M, Brinkman K, Geerlings S, Smit C, Thyagarajan K, Sighem A v, de Wolf F, Hallett TB; ATHENA observational cohort.
Lancet Infect Dis. 2015 Jul;15(7):810-8. Abstract

HIV resistance testing and detected drug resistance in Europe.
Schultze A, Phillips AN, Paredes R, Battegay M, Rockstroh JK, Machala L, Tomazic J, Girard PM, Januskevica I, Gronborg-Laut K, Lundgren JD, Cozzi-Lepri A;EuroSIDA in EuroCOORD
AIDS. 2015 Jul 17;29(11):1379-89.  Abstract

Retinal structure and function in perinatally HIV-infected and cART-treated children: A matched case-control study
Demirkaya N, Cohen S, Wit FW, Abramoff MD, Schlingemann RO, Kuijpers TW, Reiss P, Pajkrt D, Verbraak FD.
Invest Ophthalmol Vis Sci. 2015 Jun 1;56(6):3945-54 Abstract

An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study
Friis-Møller N, Ryom L, Smith C, Weber R, Reiss P, Dabis F, De Wit S, Monforte AD, Kirk O, Fontas E, Sabin C, Phillips A, Lundgren J, Law M;D:A:D study group
Eur J Prev Cardiol. 2015 Apr 16 Abstract

Low mother-to-child-transmission rate of Hepatitis C virus in cART treated HIV-1 infected Mothers
Snijdewind I, Smit C, Schutten M, Nellen FJB, Kroon FP, Reiss P, van der Ende ME
J Clin Virol. 2015 Jul;68:11-5. Abstract

GBD 2013 and HIV incidence in high income countries
Supervie V, Archibald CP, Costagliola D, Delpech V, Hall HI, Lot F, van Sighem A, Wilson DP.
Lancet. 2015 Mar 28;385(9974):1177. doi: 10.1016/S0140-6736(15)60626-2. Abstract

Use of surveillance data on HIV diagnoses with HIV-related symptoms to estimate the number of people living with undiagnosed HIV in need of antiretroviral therapy.
Lodwick RK, Nakagawa F, van Sighem A, Sabin CA, Phillips AN
PLoS One. 2015 Mar 13;10(3):e0121992 Abstract

Injection drug use and hepatitis C as risk factors for mortality in HIV-infected individuals: The Antiretroviral Therapy Cohort Collaboration
May MT, Justice AC, Birnie K, Ingle SM, Smit C, Smith C, Neau D, Guiguet M, Schwarze-Zander C, Moreno S, Guest JL, Monforte Ad, Tural C, Gill MJ,Bregenzer A, Kirk O, Saag M, Sterling TR, Crane HM, Sterne JA
J Acquir Immune Defic Syndr. 2015 Jul 1;69(3):348-54 Abstract

Changing patterns of undiagnosed HIV infection in the Netherlands: Who benefits most from intensified HIV test and treat policies?
Op de Coul EL, Schreuder I, Conti S, van Sighem A, Xiridou M, Van Veen MG, Heijne JC
PLoS One. 2015 Jul 17;10(7):e0133232 Abstract

Liver-related death among HIV/hepatitis C virus-co-infected individuals: implications for the era of directly acting antivirals.
Grint D, Peters L, Rockstroh JK, Rakmanova A, Trofimova T, Lacombe K, Karpov I, Galli M, Domingo P, Kirk O, Lundgren JD, Mocroft A; EuroSIDA in EuroCoord.
AIDS. 2015 Jun 19;29(10):1205-15.  Abstract

Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study
Mocroft A, Lundgren JD, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Neuhaus J, Fux CA, Moranne O, Morlat P, Johnson MA, Ryom L; D:A:D study group; Royal Free Hospital Clinic Cohort; INSIGHT study group; SMART study group; ESPRIT study group.
PLoS Med. 2015 Mar 31;12(3):e1001809. doi: 10.1371/journal.pmed.1001809. eCollection 2015. Abstract

Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients.
Antiretroviral Therapy Cohort Collaboration (ART-CC), Vandenhende MA, Ingle S, May M, Chene G, Zangerle R, Van Sighem A, Gill MJ, Schwarze-Zander C,Hernandez-Novoa B, Obel N, Kirk O, Abgrall S, Guest J, Samji H, D'Arminio Monforte A, Llibre JM, Smith C, Cavassini M, Burkholder GA, Shepherd B, Crane HM,Sterne J, Morlat P.
AIDS. 2015 Jan 28;29(3):373-83. doi: 10.1097/QAD.0000000000000544. Abstract

Cancer risk and use of protease inhibitor or non-nucleoside reverse transcriptase inhibitor based combination antiretroviral therapy: the D:A:D study
Bruyand M, Ryom L, Shepherd L, Fatkenheuer G, Grulich A, Reiss P, de Wit S, D Arminio Monforte A, Furrer H, Pradier C, Lundgren J, Sabin C; D:A:D studygroup.
J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):568-77. doi: 10.1097/QAI.0000000000000523. Abstract

Efficacy of etravirine combined with darunavir or other ritonavir-boosted protease inhibitors in HIV-1-infected patients: an observational study using pooled European cohort data.
Vingerhoets J, Calvez V, Flandre P, Marcelin AG, Ceccherini-Silberstein F, Perno CF, Mercedes Santoro M, Bateson R, Nelson M, Cozzi-Lepri A, Grarup J,Lundgren J, Incardona F, Kaiser R, Sonnerborg A, Clotet B, Paredes R, Günthard HF, Ledergerber B, Hoogstoel A, Nijs S, Tambuyzer L, Lavreys L, Opsomer M;Etravirine Cohort Study Group.
HIV Med. 2015 May;16(5):297-306.  Abstract

Boosted lopinavir vs. boosted atazanavir-containing regimens and immunologic, virologic and clinical outcomes: A prospective study of HIV-infected individuals in high-income countries 
The HIV-CAUSAL Collaboration.
Clin Infect Dis. 2015 Jan 6. pii: ciu1167. [Epub ahead of print] Abstract

Diminished impact of ethnicity as a risk factor for chronic kidney disease in the current HIV treatment era
Schoffelen AF, Smit C, van Lelyveld SF, Vogt L, Bauer MP, Reiss P, Hoepelman AI, Barth RE; on behalf of the ATHENA national observational HIV cohort.
J Infect Dis. 2015 Jan 18. pii: jiv026. [Epub ahead of print] Abstract

Multivariate normative comparison, a novel method for more reliably detecting cognitive impairment in HIV infection
Su T, Schouten J, Geurtsen GJ, Wit FW, Stolte IG, Prins M, Portegies P, Caan MW, Reiss P, Majoie CB, Schmand BA; the AGEhIV Cohort Study Group.
AIDS. 2015 Jan 14. [Epub ahead of print] Abstract

Country of Birth Does Not Influence Long-term Clinical, Virologic, and Immunological Outcome of HIV-Infected Children Living in the Netherlands: A Cohort Study Comparing Children Born in the Netherlands With Children Born in Sub-Saharan Africa
Cohen S, van Bilsen WP, Smit C, Fraaij PL, Warris A, Kuijpers TW, Geelen SP, Wolfs TF, Scherpbier HJ, van Rossum AM, Pajkrt D.
J Acquir Immune Defic Syndr. 2015 Feb 1;68(2):178-85. doi: 10.1097/QAI.0000000000000431. Abstract


Stichting HIV Monitoring

Stichting HIV Monitoring (SHM) levert een belangrijke en noodzakelijke bijdrage aan de zorg voor mensen met hiv in Nederland. Door middel van het verzamelen en bewerken van gecodeerde data van hiv-positieve personen uit het hele land draagt ons monitor-onderzoek structureel bij aan de kennis over hiv en stelt het behandelend artsen in staat om de zorg voor hun patiënten continu te verbeteren. Ons jaarlijkse Monitoring Report geeft waardevolle input voor het ontwikkelen van hiv-zorg en preventiebeleid in Nederland en binnen de Europese Unie.


Nicolaes Tulphuis
Tafelbergweg 51
1105 BD Amsterdam


Academisch Medisch Centrum
Universiteit van Amsterdam
Meibergdreef 9 1105 AZ Amsterdam

© Stichting HIV Monitoring  | Disclaimer  | Colofon